{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:08:54Z","timestamp":1768032534099,"version":"3.49.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T00:00:00Z","timestamp":1206489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11154-008-9075-3","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T16:25:47Z","timestamp":1206462347000},"page":"171-180","source":"Crossref","is-referenced-by-count":63,"title":["Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation"],"prefix":"10.1007","volume":"9","author":[{"given":"Murat","family":"Bastepe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,26]]},"reference":[{"key":"9075_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008480-199908000-00012","volume":"11","author":"WL Miller","year":"1999","unstructured":"Miller WL, Portale AA. Genetic causes of rickets. Curr Opin Pediatr. 1999;11:333\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"Suppl 2","key":"9075_CR2","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1542\/peds.2006-2023F","volume":"119","author":"MB Demay","year":"2007","unstructured":"Demay MB, Sabbagh Y, Carpenter TO. Calcium and vitamin D: what is known about the effects on growing bone. Pediatrics. 2007;119 Suppl 2:S141\u20134.","journal-title":"Pediatrics"},{"key":"9075_CR3","doi-asserted-by":"crossref","unstructured":"J\u00fcppner H, Thakker R. Genetic disorders of calcium and phosphate homeostasis. In: Pollak M (ed) The kidney. W.B. Saunders Company, Philadelphia, PA; 2008. (in press).","DOI":"10.1016\/B978-1-4160-0252-9.50023-9"},{"key":"9075_CR4","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A. 2005;102:9637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9075_CR5","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/sj.ki.5001813","volume":"70","author":"IC Forster","year":"2006","unstructured":"Forster IC, Hernando N, Biber J, Murer H. Proximal tubular handling of phosphate: a molecular perspective. Kidney Int. 2006;70:1548\u201359.","journal-title":"Kidney Int"},{"key":"9075_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jsbmb.2006.12.090","volume":"103","author":"HS Tenenhouse","year":"2007","unstructured":"Tenenhouse HS. Phosphate transport: molecular basis, regulation and pathophysiology. J Steroid Biochem Mol Biol. 2007;103:572\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9075_CR7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000107069","volume":"27","author":"K Miyamoto","year":"2007","unstructured":"Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol. 2007;27:503\u201315.","journal-title":"Am J Nephrol"},{"key":"9075_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-012286551-0\/50009-9","volume-title":"Pediatric bone: biology and diseases","author":"R St-Arnaud","year":"2003","unstructured":"St-Arnaud R, Demay MB. Vitamin D biology. In: Glorieux FH, Juppner H, Pettifor JM, editors. Pediatric bone: biology and diseases. San Diego: Academic; 2003. p. 193\u2013216."},{"key":"9075_CR9","first-page":"1377","volume-title":"Endocrinology","author":"H J\u00fcppner","year":"2005","unstructured":"J\u00fcppner H, Gardella T, Brown E, Kronenberg H, Potts J Jr. Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development. In: DeGroot L, Jameson J, editors. Endocrinology. 5th ed. Philadelphia, PA: W.B. Saunders Company; 2005. p. 1377\u2013417.","edition":"5"},{"key":"9075_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-540-34891-7_12","volume":"179","author":"AR Mensenkamp","year":"2007","unstructured":"Mensenkamp AR, Hoenderop JG, Bindels RJ. TRPV5, the gateway to Ca2+ homeostasis. Handb Exp Pharmacol. 2007;179:207\u201320.","journal-title":"Handb Exp Pharmacol"},{"key":"9075_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"9075_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/B978-012286551-0\/50026-9","volume-title":"Pediatric bone: biology and diseases","author":"AA Portale","year":"2003","unstructured":"Portale AA, Miller WL. Rickets due to hereditary abnormalities of vitamin D synthesis and action. In: Glorieux FH, Juppner H, Pettifor JM, editors. Pediatric bone: biology and diseases. San Diego: Academic; 2003. p. 583\u2013602."},{"key":"9075_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/B978-012286551-0\/50027-0","volume-title":"Pediatric bone: biology and diseases","author":"IA Holm","year":"2003","unstructured":"Holm IA, Econs MJ, Carpenter TO. Familial hypophosphatemia and related disorders. In: Glorieux FH, Juppner H, Pettifor JM, editors. Pediatric bone: biology and diseases. San Diego, CA: Academic; 2003. p. 603\u201331."},{"issue":"3","key":"9075_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","volume":"27","author":"K White","year":"2006","unstructured":"White K, Larsson T, Econs M. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: Frp-4, MEPE, and FGF23. Endocr Rev. 2006;27 3:221\u201341.","journal-title":"Endocr Rev"},{"key":"9075_CR15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","volume":"330","author":"M Econs","year":"1994","unstructured":"Econs M, Drezner M. Tumor-induced osteomalacia\u2014unveiling a new hormone. N Engl J Med. 1994;330:1679\u201381.","journal-title":"N Engl J Med"},{"key":"9075_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"KE White","year":"2000","unstructured":"ADHR Consortium T; White KE, Evans WE, O\u2019Riordan JLH, Speer MC, Econs MJ, et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345\u20138.","journal-title":"Nat Genet"},{"key":"9075_CR17","first-page":"287","volume":"7","author":"JW Bianchine","year":"1971","unstructured":"Bianchine JW, Stambler AA, Harrison HE. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser. 1971;7:287\u201395.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"9075_CR18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","volume":"82","author":"M Econs","year":"1997","unstructured":"Econs M, McEnery P. Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab. 1997;82:674\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR19","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI119809","volume":"100","author":"M Econs","year":"1997","unstructured":"Econs M, McEnery P, Lennon F, Speer M. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest. 1997;100:2653\u20137.","journal-title":"J Clin Invest"},{"issue":"4","key":"9075_CR20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","volume":"22","author":"EA Imel","year":"2007","unstructured":"Imel EA, Hui SL, Econs MJ. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J. Bone Mineral Res. 2007;22(4):520\u20136 (Apr).","journal-title":"J. Bone Mineral Res."},{"key":"9075_CR21","first-page":"305","volume":"55","author":"K Kruse","year":"2001","unstructured":"Kruse K, Woelfel D, Strom T. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res. 2001;55:305\u20138.","journal-title":"Horm Res"},{"key":"9075_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561\u20138.","journal-title":"J Clin Invest"},{"key":"9075_CR23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 2004;23:421\u201332.","journal-title":"Matrix Biol"},{"key":"9075_CR24","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab. 2006;291:E38\u201349.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9075_CR25","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA. 2001;98:6500\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9075_CR26","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology. 2002;143:3179\u201382.","journal-title":"Endocrinology"},{"key":"9075_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","volume":"35","author":"A Benet-Pages","year":"2004","unstructured":"Benet-Pages A, Lorenz-Depiereux B, Zischka H, White K, Econs M, Strom T. FGF23 is processed by proprotein convertases but not by PHEX. Bone. 2004;35:455\u201362.","journal-title":"Bone"},{"key":"9075_CR28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00424-007-0231-5","volume":"454","author":"TJ Berndt","year":"2007","unstructured":"Berndt TJ, Craig TA, McCormick DJ, Lanske B, Sitara D, Razzaque MS, et al. Biological activity of FGF-23 fragments. Pflugers Arch. 2007;454:615\u201323.","journal-title":"Pflugers Arch"},{"key":"9075_CR29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","volume":"17","author":"S Jan De Beur","year":"2002","unstructured":"Jan De Beur S, Finnegan R, Vassiliadis J, Cook B, Barberio D, Estes S, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res. 2002;17:1102\u201310.","journal-title":"J Bone Miner Res"},{"key":"9075_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"K White","year":"2001","unstructured":"White K, Jonsson K, Carn G, Hampson G, Spector T, Mannstadt M, et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab. 2001;86:497\u2013500.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman D, Bergman R, Indelman M, Ratajczak P, Mizrachi M, et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet. 2004;36:579\u201381.","journal-title":"Nat Genet"},{"key":"9075_CR32","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2004-2302","volume":"90","author":"S Ichikawa","year":"2005","unstructured":"Ichikawa S, Lyles K, Econs M. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab. 2005;90:2420\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR33","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"Perwad F, Azam N, Zhang M, Yamashita T, Tenenhouse H, Portale A. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 2005;146:5358\u201364.","journal-title":"Endocrinology"},{"key":"9075_CR34","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","volume":"293","author":"F Perwad","year":"2007","unstructured":"Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:F1577\u201383.","journal-title":"Am J Physiol Renal Physiol"},{"key":"9075_CR35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"S Ferrari","year":"2005","unstructured":"Ferrari S, Bonjour J, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90:1519\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"S Burnett","year":"2006","unstructured":"Burnett S, Gunawardene S, Bringhurst F, J\u00fcppner H, Lee H, Finkelstein J. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21:1187\u201396.","journal-title":"J Bone Miner Res"},{"key":"9075_CR37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"TH Consortium","year":"1995","unstructured":"Consortium TH. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11:130\u20136.","journal-title":"Nat Genet"},{"key":"9075_CR38","first-page":"790","volume":"60","author":"IA Holm","year":"1997","unstructured":"Holm IA, Huang X, Kunkel LM. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet. 1997;60:790\u20137.","journal-title":"Am J Hum Genet"},{"key":"9075_CR39","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab. 2002;87:4957\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR40","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"K Jonsson","year":"2003","unstructured":"Jonsson K, Zahradnik R, Larsson T, White K, Sugimoto T, Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. New Engl J Med. 2003;348:1656\u201362.","journal-title":"New Engl J Med"},{"key":"9075_CR41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","volume":"18","author":"T Weber","year":"2003","unstructured":"Weber T, Liu S, Indridason O, Quarles L. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res. 2003;18:1227\u201334.","journal-title":"J Bone Miner Res"},{"key":"9075_CR42","unstructured":"Aono Y, Shimada T, Yamazaki Y, Hino R, Takeuchi M, Fujita T, et al. The neutralization of FGF-23 ameliorates hypophosphatemia and rickets in Hyp mice. Meeting of the American Society for Bone and Mineral Research, Minneapolis, Minnesota, 2003; p 1056."},{"key":"9075_CR43","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1681\/ASN.2004121060","volume":"16","author":"S Liu","year":"2005","unstructured":"Liu S, Brown T, Zhou J, Xiao Z, Awad H, Guilak F, et al. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol. 2005;16:91645\u201353.","journal-title":"J Am Soc Nephrol"},{"key":"9075_CR44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1006\/bbrc.2001.5084","volume":"284","author":"A Bowe","year":"2001","unstructured":"Bowe A, Finnegan R, Jan de Beur S, Cho J, Levine M, Kumar R, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun. 2001;284:977\u201381.","journal-title":"Biochem Biophys Res Commun"},{"key":"9075_CR45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1302\/0301-620X.60B3.681423","volume":"60-B","author":"W Perry","year":"1978","unstructured":"Perry W, Stamp T. Hereditary hypophosphataemic rickets with autosomal recessive inheritance and severe osteosclerosis. A report of two cases. J Bone Joint Surg Br. 1978;60-B:430\u20134.","journal-title":"J Bone Joint Surg Br"},{"key":"9075_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/adc.56.3.203","volume":"56","author":"C Scriver","year":"1981","unstructured":"Scriver C, Reade T, Halal F, Costa T, Cole D. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3. Arch Dis Child. 1981;56:203\u20137.","journal-title":"Arch Dis Child"},{"key":"9075_CR47","first-page":"S558","volume":"14","author":"M Bastepe","year":"1999","unstructured":"Bastepe M, Shlossberg H, Murdock H, J\u00fcppner H, Rittmaster R. A Lebanese family with osteosclerosis and hypophosphatemia. J Bone Miner Res. 1999;14:S558.","journal-title":"J Bone Miner Res"},{"key":"9075_CR48","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pag\u00e8s A, Amyere M, Wagenstaller J, M\u00fcller-Barth U, et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet. 2006;38:1248\u201350.","journal-title":"Nat Genet"},{"key":"9075_CR49","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38:1310\u20135.","journal-title":"Nat Genet"},{"key":"9075_CR50","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1016\/S0021-9258(18)31434-0","volume":"268","author":"A George","year":"1993","unstructured":"George A, Sabsay B, Simonian PA, Veis A. Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem. 1993;268:12624\u201330.","journal-title":"J Biol Chem"},{"key":"9075_CR51","doi-asserted-by":"crossref","first-page":"17500","DOI":"10.1074\/jbc.M212700200","volume":"278","author":"K Narayanan","year":"2003","unstructured":"Narayanan K, Ramachandran A, Hao J, He G, Park KW, Cho M, et al. Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store. J Biol Chem. 2003;278:17500\u20138.","journal-title":"J Biol Chem"},{"key":"9075_CR52","first-page":"308","volume":"7","author":"A George","year":"2007","unstructured":"George A, Ramachandran A, Albazzaz M, Ravindran S. DMP1\u2014a key regulator in mineralized matrix formation. J Musculoskelet Neuronal Interact. 2007;7:308.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"9075_CR53","unstructured":"Lu Y, Liu S, Yu S, Xie Y, Zhou J, Quarles L, et al. The 57\u00a0kDa C-terminal fragment of Dentin Matrix Protein 1 (DMP1) retains all biological activity: Osteocytic regulation of Pi homeostasis through FGF23. 29. Annual Meeting of American Society Bone and Mineral Research, Honolulu, Hawai, 2007."},{"key":"9075_CR54","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1074\/jbc.M412911200","volume":"280","author":"L Ye","year":"2005","unstructured":"Ye L, Mishina Y, Chen D, Huang H, Dallas S, Dallas M, et al. Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J Biol Chem. 2005;280:6197\u2013203.","journal-title":"J Biol Chem"},{"key":"9075_CR55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/dvg.20370","volume":"46","author":"JQ Feng","year":"2008","unstructured":"Feng JQ, Scott G, Guo D, Jiang B, Harris M, Ward T, et al. Generation of a conditional null allele for Dmp1 in mouse. Genesis. 2008;46:87\u201391.","journal-title":"Genesis"},{"key":"9075_CR56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/154405910708600404","volume":"86","author":"Y Lu","year":"2007","unstructured":"Lu Y, Xie Y, Zhang S, Dusevich V, Bonewald LF, Feng JQ. DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res. 2007;86:320\u20135.","journal-title":"J Dent Res"},{"key":"9075_CR57","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmg.26.9.572","volume":"26","author":"P Beighton","year":"1989","unstructured":"Beighton P. Osteoglophonic dysplasia. J Med Genet. 1989;26:572\u20136.","journal-title":"J Med Genet"},{"key":"9075_CR58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01644343","volume":"10","author":"P Beighton","year":"1980","unstructured":"Beighton P, Cremin BJ, Kozlowski K. Osteoglophonic dwarfism. Pediatr Radiol. 1980;10:46\u201350.","journal-title":"Pediatr Radiol"},{"issue":"Suppl 2","key":"9075_CR59","first-page":"S4","volume":"18","author":"K White","year":"2003","unstructured":"White K, Cabral J, Evans W, Ichikawa S, Davis S, Ornitz D, et al. A missense mutation in FGFR1 causes a novel syndrome: craniofacial dysplasia with hypophosphatemia (CFDH). J Bone Miner Res. 2003;18 Suppl 2:S4.","journal-title":"J Bone Miner Res"},{"key":"9075_CR60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajmg.a.31106","volume":"140","author":"E Farrow","year":"2006","unstructured":"Farrow E, Davis S, Mooney S, Beighton P, Mascarenhas L, Gutierrez Y, et al. Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am J Med Genet. 2006;140:537\u20139.","journal-title":"Am J Med Genet"},{"key":"9075_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1194-269","volume":"8","author":"M Muenke","year":"1994","unstructured":"Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 1994;8:269\u201374.","journal-title":"Nat Genet"},{"key":"9075_CR62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1096-8628(20000703)93:1<22::AID-AJMG5>3.0.CO;2-U","volume":"93","author":"T Roscioli","year":"2000","unstructured":"Roscioli T, Flanagan S, Kumar P, Masel J, Gattas M, Hyland VJ, et al. Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am J Med Genet. 2000;93:22\u20138.","journal-title":"Am J Med Genet"},{"key":"9075_CR63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","volume":"134","author":"W Hoffman","year":"2005","unstructured":"Hoffman W, J\u00fcppner H, Deyoung B, O\u2019dorisio M, Given K. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am J Med Genet A. 2005;134:233\u20136.","journal-title":"Am J Med Genet A"},{"key":"9075_CR64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.a.30915","volume":"139","author":"C Heike","year":"2005","unstructured":"Heike C, Cunningham M, Steiner R, Wenkert D, Hornung R, Gruss J, et al. Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis? Am J Med Genet A. 2005;139:67\u201377.","journal-title":"Am J Med Genet A"},{"key":"9075_CR65","first-page":"675","volume":"22","author":"L Weinstein","year":"2001","unstructured":"Weinstein L, Yu S, Warner D, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev. 2001;22:675\u2013705.","journal-title":"Endocr Rev"},{"key":"9075_CR66","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. New Engl J Med. 1991;325:1688\u201395.","journal-title":"New Engl J Med"},{"key":"9075_CR67","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1073\/pnas.89.11.5152","volume":"89","author":"W Schwindinger","year":"1992","unstructured":"Schwindinger W, Francomano C, Levine M. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune\u2013Albright syndrome. Proc Natl Acad Sci U S A. 1992;89:5152\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9075_CR68","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins M, Fedarko N, Cherman N, Corsi A, White K, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112:683\u201392.","journal-title":"J Clin Invest"},{"key":"9075_CR69","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci. 2006;78:2295\u2013301.","journal-title":"Life Sci"},{"key":"9075_CR70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","volume":"23","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto T, Imanishi Y, Kinoshita E, Nakagomi Y, Shimizu N, Miyauchi A, et al. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune\u2013Albright syndrome. J Bone Miner Metab. 2005;23:231\u20137.","journal-title":"J Bone Miner Metab"},{"key":"9075_CR71","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.95.9.5372","volume":"95","author":"L Beck","year":"1998","unstructured":"Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS. Targeted inactivation of Ntp2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A. 1998;95:5372\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9075_CR72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM198503073121003","volume":"312","author":"M Tieder","year":"1985","unstructured":"Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med. 1985;312:611\u20137.","journal-title":"N Engl J Med"},{"key":"9075_CR73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM198701153160302","volume":"316","author":"M Tieder","year":"1987","unstructured":"Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, et al. \u201cIdiopathic\u201d hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med. 1987;316:125\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"9075_CR74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium\/phosphate cotransporter gene SLC34A3. Am J Human Genet. 2006;78 2:193\u2013201.","journal-title":"Am J Human Genet"},{"key":"9075_CR75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00774-007-0776-6","volume":"25","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Michigami T, Aranami F, Segawa H, Yoh K, Nakajima S, et al. Hereditary hypophosphatemic rickets with hypercalciuria: a study for the phosphate transporter gene type IIc and osteoblastic function. J Bone Miner Metab. 2007;25:407\u201313.","journal-title":"J Bone Miner Metab"},{"key":"9075_CR76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V123507","volume":"12","author":"A Jones","year":"2001","unstructured":"Jones A, Tzenova J, Frappier D, Crumley M, Roslin N, Kos C, et al. Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na\/Pi cotransporter NPT2 gene. J Am Soc Nephrol. 2001;12:507\u201314.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"9075_CR77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"Bergwitz C, Roslin N, Tieder M, Loredo-Osti J, Bastepe M, Abu-Zahra H, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) predict a key role for the sodium-phosphate co-transporter NaPi-IIc in maintaining phosphate homeostasis and skeletal function. Am J Human Genet. 2006;78 2:179\u201392.","journal-title":"Am J Human Genet"},{"key":"9075_CR78","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/jc.2005-2840","volume":"91","author":"S Ichikawa","year":"2006","unstructured":"Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, Econs MJ. Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab. 2006;91:4022\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9075_CR79","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Pri\u00e9","year":"2002","unstructured":"Pri\u00e9 D, Huart V, Bakouh N, Planelles G, Dellis O, G\u00e9rard B, et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med. 2002;347:983\u201391.","journal-title":"N Engl J Med"},{"key":"9075_CR80","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1359\/jbmr.2003.18.12.2135","volume":"18","author":"L Virkki","year":"2003","unstructured":"Virkki L, Forster I, Hernando N, Biber J, Murer H. Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J Bone Miner Res. 2003;18:2135\u201341.","journal-title":"J Bone Miner Res"},{"key":"9075_CR81","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/sj.ki.5000437","volume":"69","author":"JY Lapointe","year":"2006","unstructured":"Lapointe JY, Tessier J, Paquette Y, Wallendorff B, Coady MJ, Pichette V, et al. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int. 2006;69:2261\u20137.","journal-title":"Kidney Int"},{"key":"9075_CR82","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975;2:309\u201310.","journal-title":"Lancet"},{"key":"9075_CR83","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","volume":"277","author":"T Yamashita","year":"2002","unstructured":"Yamashita T, Konishi M, Miyake A, Inui K, Itoh N. Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem. 2002;277:28265\u201370.","journal-title":"J Biol Chem"},{"key":"9075_CR84","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770\u20134.","journal-title":"Nature"},{"key":"9075_CR85","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, et al. Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem. 2006;281:6120\u20133.","journal-title":"J Biol Chem"},{"key":"9075_CR86","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest. 2007;117:2684\u201391.","journal-title":"J Clin Invest"},{"key":"9075_CR87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/bbrc.1999.2009","volume":"267","author":"Y Kato","year":"2000","unstructured":"Kato Y, Arakawa E, Kinoshita S, Shirai A, Furuya A, Yamano K, et al. Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun. 2000;267:597\u2013602.","journal-title":"Biochem Biophys Res Commun"},{"key":"9075_CR88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1247\/csf.29.91","volume":"29","author":"SA Li","year":"2004","unstructured":"Li SA, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct. 2004;29:91\u20139.","journal-title":"Cell Struct Funct"},{"key":"9075_CR89","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","volume":"289","author":"OI Kolek","year":"2005","unstructured":"Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal\u2013gastrointestinal\u2013skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1036\u201342.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9075_CR90","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","volume":"116","author":"R Masuyama","year":"2006","unstructured":"Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest. 2006;116:3150\u20139.","journal-title":"J Clin Invest"},{"key":"9075_CR91","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro OM, Mohammadi M, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117:4003\u20138.","journal-title":"J Clin Invest"},{"key":"9075_CR92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol. 2007;195:125\u201331.","journal-title":"J Endocrinol"},{"key":"9075_CR93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45\u201351.","journal-title":"Nature"},{"key":"9075_CR94","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1568-1637(02)00027-2","volume":"1","author":"Y Nabeshima","year":"2002","unstructured":"Nabeshima Y. Klotho: a fundamental regulator of aging. Ageing Res Rev. 2002;1:627\u201338.","journal-title":"Ageing Res Rev"},{"key":"9075_CR95","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, et al. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol. 2007;18:2683\u20138.","journal-title":"J Am Soc Nephrol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9075-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-008-9075-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9075-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T07:51:31Z","timestamp":1684309891000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-008-9075-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,26]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9075"],"URL":"https:\/\/doi.org\/10.1007\/s11154-008-9075-3","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,26]]}}}